Now is not a good time to be in the prediction business. So many attempts to foretell the future go horribly wrong. At the top end of town, business, technology and political heroes celebrated at the World Economic Forum’s meeting in Davos in 2018 became the zeroes in 2019. Because the world is changing so…
A company pioneering a drug to delay cataracts from forming or slow their growth has won this year’s $100,000 Enterprize competition. Adelaide-based Calpain Therapeutics’ victory was announced earlier this month by University of Queensland Business School, which has run Australia’s richest business-plan contest since 2000.
Brisbane’s innovation engine is humming right now but could soon be spluttering for want of a key driver – skilled labour. At least that is the fear of businesses in Queensland’s capital. First, the good news on the Brisbane Innovation Scorecard (based on a survey of 372 firms, developed by Brisbane Marketing in partnership with…
It’s not too late to enter the University of Queensland Business School (UQBS) Enterprize 2011 business competition… but, well, let’s just say it’s getting pretty close. The door on new entries closes TODAY, 22 July. Aspiring entrepreneurs have until midnight to submit their concept plans and to be eligible for the grand prize: $100,000 in seed funding.
At the best of times (or worst), innovation is a key ingredient in the cocktail of a city’s success, and determines how well it is likely to continuously reinvent itself. So, last year, when Brisbane Marketing joined hands with accounting firm Deloitte and others to measure business innovation in the city, it was a smart move, or shall we say an innovative one.
End of content
End of content
GET THIS AMAZEBALLS THING!
Click the button to get it now
